Morgan Stanley's $78 Equal-Weight Makes It the Lone QNT Bear

The Lone Bear on a Street Full of Bulls

On June 29, Morgan Stanley's Joseph Moore initiated Quantinuum at equal-weight with a $78 price target — and in doing so became the single most cautious voice covering the stock. That matters because the rest of the sell side showed up bullish: in the days prior, Quantinuum collected a stack of Buy and Overweight initiations from firms including Cantor Fitzgerald. Moore isn't bearish on the technology — his note credits Quantinuum's trapped-ion architecture, demonstrated roadmap execution and its mix of government and commercial partnerships as best-in-class. He just won't underwrite the multiple, valuing the company at roughly 12x an estimated 2030 revenue of $2.5 billion discounted back to 2027, and flagging that the industry is early enough that "significant uncertainty" still surrounds commercialization and competitive positioning. A $78 target sits only modestly above spot, and coming from the lone skeptic it reads less like upside and more like a ceiling.

The Numbers Moore Won't Pay Up For

Strip out the quantum narrative and Quantinuum's income statement is exactly the tension Moore is pricing. The company did $30.9 million of revenue in 2025 against a $192.6 million net loss and roughly $263 million of free-cash-flow burn. More striking, Q1 revenue actually *fell* 73% year over year to $5.24 million as a tough prior-year comparison rolled off, even as the quarterly net loss widened to $136.5 million. Against a market cap that has hovered near $14 billion, that put QNT's EV/sales above 350 at the IPO versus roughly 133 for IonQ — a richer multiple on a smaller, shrinking top line. None of this is new information; the gap between valuation and fundamentals was always the bear case. But an equal-weight from a bulge-bracket bank is the kind of thing that makes a market actually stop and look at it. Moore just signed his name to the thing the bulls keep waving off.

Why It Hits QNT Harder Than the Group

QNT is the highest-beta expression of a high-beta group. The pure-play quantum names — IonQ, Rigetti, D-Wave — routinely swing 5-7% in a single session on no company-specific news, trading on theme and sentiment rather than fundamentals. Quantinuum is the newest and lowest-float name in that basket, public only since its June 4 Nasdaq debut at a $60 IPO price, so it travels furthest in both directions — which is exactly what HIPERWIRE has tracked through QNT's whipsaw rips and unwinds across the back half of June. A thin float that amplifies a downgrade also amplifies the next overhang: the December 2026 lock-up expiration that will release a wave of insider supply into a stock still searching for its clearing price. The first full post-IPO earnings print and any concrete commercial or government contract are the next events that can reset the tape in either direction — until then, QNT trades the multiple, and the multiple just lost its loudest defender's benefit of the doubt.